Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering

Tissue Engineering - Part A

Volumn 18, Issue 21-22, 2012, Pages 2303-2314

  Liu, Jun ^a,b   Zhou, Hongzhi ^a   Weir, Michael D ^a   Xu, Hockin H K ^a,c,d   Chen, Qianming ^b   Trotman, Carroll Ann ^a,e  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d University of Marylandw Baltimore County   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINATE MATRIX; ARG GLY ASPS; CELL ENCAPSULATIONS; CELL VIABILITY; CREATINE KINASE; DEFECT VOLUME; HUMAN UMBILICAL CORD; HYDROGEL MATRIX; INVASIVE SURGERY; MACROPORES; MESENCHYMAL STEM CELL; MICROBEADS; MUSCLE REGENERATION; MUSCLE TISSUES; THREE-DIMENSIONAL SCAFFOLDS;

ALGINATE; CYTOLOGY; HYDROGELS; MUSCLE; TISSUE ENGINEERING;

STEM CELLS;

ALGINIC ACID; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; GLUCURONIC ACID; HEXURONIC ACID; MICROSPHERE; OLIGOPEPTIDE;

ARTICLE; BIOREMEDIATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYDROGEL; IMMOBILIZED CELL; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MUSCLE; MUSCLE DEVELOPMENT; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; STAINING; STEM CELL; TISSUE ENGINEERING; UMBILICAL CORD;

ALGINATES; BIODEGRADATION, ENVIRONMENTAL; CELL SURVIVAL; CELLS, IMMOBILIZED; GENE EXPRESSION REGULATION; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGEL; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MUSCLE DEVELOPMENT; MUSCLES; OLIGOPEPTIDES; STAINING AND LABELING; STEM CELLS; TISSUE ENGINEERING; UMBILICAL CORD;

EID: 84868592340     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0658     Document Type: Article

References (69)

1. Mao, J.J., Vunjak-Novakovic, G., Mikos, A.G., and Atala, A. Regenerative Medicine: Translational Approaches and Tissue Engineering. Boston, MA: Artech House, 2007.
2. Johnson, P.C., Mikos, A.G., Fisher, J.P., and Jansen, J.A. Strategic directions in tissue engineering. Tissue Eng 13, 2827, 2007.
3. Koning, M., Harmsen, M.C., van Luyn, M.J., and Werker, P.M. Current opportunities and challenges in skeletal muscle tissue engineering. J Tissue Eng Regen Med 3, 407, 2009.
4. Mikos, A.G., Herring, S.W., Ochareon, P., Elisseeff, J., Lu, H.H., Kandel, R., Schoen, F.J., Toner, M., Mooney, D., Atala, A., Van Dyke, M.E., Kaplan, D., and Vunjak-Novakovic, G. Engineering complex tissues. Tissue Eng 12, 3307, 2006.
5. Kuang, S., Gillespie, M.A., and Rudnicki, M.A. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2, 22, 2008.
6. Meng, J., Muntoni, F., and Morgan, J.E. Stem cells to treat muscular dystrophies-Where are we? Neuromuscul Disord 21, 4, 2011.
7. Dezawa, M., Ishikawa, H., Itokazu, Y., Yoshihara, T., Hoshino, M., Takeda, S., Ide, C., and Nabeshima, Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309, 314, 2005.
8. Wang, H.S., Hung, S.C., Peng, S.T., Huang, C.C., Wei, H.M., Guo, Y.J., Fu, Y.S., Lai, M.C., and Chen, C.C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22, 1330, 2004.
9. Troyer, D.L., andWeiss,M.L.Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26, 591, 2008.
10. Zhao, L., Weir, M.D., and Xu, H.H. An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 31, 6502, 2010.
11. Zhao, L., Weir, M.D., and Xu, H.H. Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 31, 3848, 2010.
12. Wang, L., Seshareddy, K., Weiss, M.L., and Detamore, M.S. Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng Part A 15, 1009, 2009.
13. Wang, L., Tran, I., Seshareddy, K., Weiss, M.L., and Detamore, M.S. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng Part A 15, 2259, 2009.
14. Conconi, M.T., Burra, P., Di Liddo, R., Calore, C., Turetta, M., Bellini, S., Bo, P., Nussdorfer, G.G., and Parnigotto, P.P. CD105( + ) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 18, 1089, 2006.
15. Kocaefe, C., Balci, D., Hayta, B.B., and Can, A. Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair. Stem Cell Rev 6, 512, 2010.
16. Qian, Q., Qian, H., Zhang, X., Zhu, W., Yan, Y., Ye, S., Peng, X., Li, W., Xu, Z., Sun, L., and Xu, W. 5-Azacytidine induces cardiac differentiation of human umbilical cord derived mesenchymal stem cells by activating extracellular regulated kinase (ERK). Stem Cells Dev 21, 67, 2012.
17. Kloxin, A.M., Kasko, A.M., Salinas, C.N., and Anseth, K.S. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324, 59, 2009.
18. Kretlow, J.D., Young, S., Klouda, L., Wong, M., and Mikos, A.G. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 21, 3368, 2009.
19. Hill, E., Boontheekul, T., and Mooney, D.J. Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng 12, 1295, 2006.
20. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.
21. Boontheekul, T., Hill, E.E., Kong, H.J., and Mooney, D.J. Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng 13, 1431, 2007.
22. Huang, Y.C., Dennis, R.G., Larkin, L., and Baar, K. Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol 98, 706, 2005.
23. Kroehne, V., Heschel, I., Schugner, F., Lasrich, D., Bartsch, J.W., and Jockusch, H. Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med 12, 1640, 2008.
24. Varghese, S., and Elisseeff, J. Hydrogels for musculoskeletal tissue engineering. Adv Polym Sci 203, 95, 2006.
25. Lee, K.Y., and Mooney, D.J. Hydrogels for tissue engineering. Chem Rev 101, 1869, 2001.
26. Cushing, M.C., Liao, J.T., Jaeggli, M.P., and Anseth, K.S. Material-based regulation of the myofibroblast phenotype. Biomaterials 28, 3378, 2007.
27. Zhou, H., and Xu, H.H.K. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials 32, 7503, 2011.
28. Chen, W., Zhou, H., Tang, M., Weir, M.D., Bao, C., and Xu, H.H.K. Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells. Tissue Eng Part A 18, 816, 2011.
29. Wakitani, S., Saito, T., and Caplan, A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18, 1417, 1995.
30. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103, 697, 1999.
31. Rowley, J.A., and Mooney, D.J. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 60, 217, 2002.
32. Boontheekul, T., Kong, H.-J., and Mooney, D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26, 2455, 2005.
33. Bouhadir, K.H., Lee, K.Y., Alsberg, E., Damm, K.L., Anderson, K.W., and Mooney, D.J. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 17, 945, 2001.
34. Fragonas, E., Valente, M., Pozzi-Mucelli, M., Toffanin, R., Rizzo, R., Silvestri, F., and Vittur, F. Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate. Biomaterials 21, 795, 2000.
35. Ahmed, N., Dreier, R., Gopferich, A., Grifka, J., and Grassel, S. Soluble signalling factors derived from differentiated cartilage tissue affect chondrogenic differentiation of rat adult marrow stromal cells. Cell Physiol Biochem 20, 665, 2007.
36. Li, J., Zhao, Z., Yang, J., Liu, J., Wang, J., Li, X., and Liu, Y. p38 MAPK mediated in compressive stress-induced chondrogenesis of rat bone marrow MSCs in 3D alginate scaffolds. J Cell Physiol 221, 609, 2009.
37. Re'em, T., Tsur-Gang, O., and Cohen, S. The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFb1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 31, 6746, 2010.
38. Maguire, T., Davidovich, A.E., Wallenstein, E.J., Novik, E., Sharma, N., Pedersen, H., Androulakis, I.P., Schloss, R., and Yarmush, M. Control of hepatic differentiation via cellular aggregation in an alginate microenvironment. Biotechnol Bioeng 98, 631, 2007.
39. Szasz, G., Gruber, W., and Bernt, E. Creatine kinase in serum: 1. Determination of optimum reaction conditions. Clin Chem 22, 650, 1976.
40. van der Velden, J.L.J., Langen, R.C.J., Kelders, M.C., Wouters, E.F.M., Janssen-Heininger, Y.M.W., and Schols, A.M. Inhibition of glycogen synthase kinase-3b activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol 290, C453, 2006.
41. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248, 1976.
42. Charge, S.B., and Rudnicki, M.A. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84, 209, 2004.
43. Dogra, C., Changotra, H., Mohan, S., and Kumar, A. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem 281, 10327, 2006.
44. Gorodetsky, R., Vexler, A., Levdansky, L., and Marx, G. Fibrin microbeads (FMB) as biodegradable carriers for cul-turing cells and for accelerating wound healing. Methods Mol Biol 238, 11, 2004.
45. Marx, G., Mou, X., Hotovely-Salomon, A., Levdansky, L., Gaberman, E., Belenky, D., and Gorodetsky, R. Heat denaturation of fibrinogen to develop a biomedical matrix. J Biomed Mater Res B Appl Biomater 84, 49, 2008.
46. Perka, C., Arnold, U., Spitzer, R.S., and Lindenhayn, K. The use of fibrin beads for tissue engineering and subsequential transplantation. Tissue Eng 7, 359, 2001.
47. Simon, C.G., Jr., Guthrie, W.F., and Wang, F.W. Cell seeding into calcium phosphate cement. J Biomed Mater Res A 68, 628, 2004.
48. Weir, M.D., Xu, H.H., and Simon, C.G., Jr. Strong calcium phosphate cement-chitosan-mesh construct containing cellencapsulating hydrogel beads for bone tissue engineering. J Biomed Mater Res A 77, 487, 2006.
49. Evangelista, M.B., Hsiong, S.X., Fernandes, R., Sampaio, P., Kong, H.-J., Barrias, C.C., Salema, R., Barbosa, M.A., Mooney, D.J., and Granja, P.L. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 28, 3644, 2007.
50. Hollister, S.J. Porous scaffold design for tissue engineering. Nat Mater 4, 518, 2005.
51. Radin, S., Chen, T., and Ducheyne, P. The controlled release of drugs from emulsified, sol gel processed silica microspheres. Biomaterials 30, 850, 2009.
52. Silva, G.A., Coutinho, O.P., and Ducheyne, P., Reis, R.L. Materials in particulate form for tissue engineering. 2. Applications in bone. J Tissue Eng Regen Med 1, 97, 2007.
53. Eiselt, P., Yeh, J., Latvala, R.K., Shea, L.D., and Mooney, D.J. Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials 21, 1921, 2000.
54. Smidsrod, O., and Skjak-Braek, G. Alginate as immobilization matrix for cells. Trends Biotechnol 8, 71, 1990.
55. Shachar, M., Tsur-Gang, O., Dvir, T., Leor, J., and Cohen, S. The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater 7, 152, 2011.
56. Hwang, C.M., Sant, S., Masaeli, M., Kachouie, N.N., Zamanian, B., Lee, S.H., and Khademhosseini, A. Fabrication of three-dimensional porous cell-laden hydrogel for tissue engineering. Biofabrication 2, 035003, 2010.
57. Ahmed, T.A., Dare, E.V., and Hincke, M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B 14, 199, 2008.
58. Yang, Y., Palmer, K.C., Relan, N., Diglio, C., and Schuger, L. Role of laminin polymerization at the epithelial mesenchymal interface in bronchial myogenesis. Development 125, 2621, 1998.
59. Relan, N.K., Yang, Y., Beqaj, S., Miner, J.H., and Schuger, L. Cell elongation induces laminin a2 chain expression in mouse embryonic mesenchymal cells: role in visceral myogenesis. J Cell Biol 147, 1341, 1999.
60. Huebsch, N., Arany, P.R., Mao, A.S., Shvartsman, D., Ali, O.A., Bencherif, S.A., et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 9, 518, 2010.
61. Tibbitt,M.W., and Anseth, K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103, 655, 2009.
62. Matsuki, K., Sasho, T., Nakagawa, K., Tahara, M., Sugioka, K., Ochiai, N., Ogino, S., Wada, Y., and Moriya, H. RGD peptide-induced cell death of chondrocytes and synovial cells. J Orthop Sci 13, 524, 2008.
63. Ruoslahti, E., and Pierschbacher, M.D. New perspectives in cell adhesion: RGD and integrins. Science 238, 491, 1987.
64. Simon, C.G., Jr., and Lin-Gibson, S. Combinatorial and high-throughput screening of biomaterials. Adv Mater 23, 369, 2011.
65. Morgan, A.W., Roskov, K.E., Lin-Gibson, S., Kaplan, D.L., Becker, M.L., and Simon Jr, C.G. Characterization and optimization of RGD-containing silk blends to support osteoblastic differentiation. Biomaterials 29, 2556, 2008.
66. Hersel, U., Dahmen, C., and Kessler, H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24, 4385, 2003.
67. Trotman, C.A., Faraway, J.J., Phillips, C., and van Aalst, J. Effects of lip revision surgery in cleft lip/palate patients. J Dent Res 89, 728, 2010.
68. Trotman, C.A., Faraway, J.J., Losken, H.W., and van Aalst, J.A. Functional outcomes of cleft lip surgery. Part II: quantification of nasolabial movement. Cleft Palate Craniofac J 44, 607, 2007.
69. Trotman, C.A., Faraway, J.J., and Essick, G.K. Threedimensional nasolabial displacement during movement in repaired cleft lip and palate patients. Plast Reconstr Surg 105, 1273, 2000.